Literature DB >> 12773437

Prediction of ovarian hyperstimulation syndrome (OHSS). Estradiol level has an important role in the prediction of OHSS.

Mohamed Aboulghar1.   

Abstract

The cascade of events that leads to the development of ovarian hyperstimulation syndrome (OHSS) is almost always accompanied by elevated estradiol (E(2)) levels. The role of estrogen level in OHSS has not been confirmed; however, it was shown repeatedly in the literature that elevated levels of E(2) constitute a risk for OHSS. Monitoring E(2) was found to be effective in reducing the incidence of OHSS. It was also reported that reducing the E(2) level by coasting helps to prevent OHSS. It is believed that irrespective of the debatable role of estrogen in the pathogenesis of OHSS, there is a general agreement that E(2) assay is an important marker to detect the majority of patients at risk of OHSS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12773437     DOI: 10.1093/humrep/deg208

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  23 in total

1.  GnRH antagonist administered twice the day before hCG trigger combined with a step-down protocol may prevent OHSS in IVF/ICSI antagonist cycles at risk for OHSS without affecting the reproductive outcomes: a prospective randomized control trial.

Authors:  Yannis Prapas; Konstantinos Ravanos; Stamatios Petousis; Yannis Panagiotidis; Achilleas Papatheodorou; Chrysoula Margioula-Siarkou; Assunta Iuliano; Giuseppe Gullo; Nikos Prapas
Journal:  J Assist Reprod Genet       Date:  2017-08-03       Impact factor: 3.412

2.  What is the best predictor of severe ovarian hyperstimulation syndrome in IVF? A cohort study.

Authors:  Theoni B Tarlatzi; Christos A Venetis; Fabienne Devreker; Yvon Englert; Anne Delbaere
Journal:  J Assist Reprod Genet       Date:  2017-07-14       Impact factor: 3.412

3.  Serum anti-Müllerian hormone and antral follicle count as predictive markers of OHSS in ART cycles.

Authors:  Pelin Ocal; Sezai Sahmay; Meral Cetin; Tulay Irez; Onur Guralp; Ismail Cepni
Journal:  J Assist Reprod Genet       Date:  2011-09-01       Impact factor: 3.412

4.  Investigation on the risk factors for late-onset OHSS: a retrospective case-control study.

Authors:  Huiyu Xu; Shuo Yang; Liyan Cui; Guoshuang Feng; Rong Li; Jie Qiao
Journal:  Arch Gynecol Obstet       Date:  2021-08-19       Impact factor: 2.344

Review 5.  The pathophysiology of ovarian hyperstimulation syndrome: an unrecognized compartment syndrome.

Authors:  Lisa C Grossman; Konstantinos G Michalakis; Hyacinth Browne; Mark D Payson; James H Segars
Journal:  Fertil Steril       Date:  2010-09       Impact factor: 7.329

6.  Can steroidal ovarian suppression during the luteal phase after oocyte retrieval reduce the risk of severe OHSS?

Authors:  Ya-Qin Wang; Jin Luo; Wang-Min Xu; Qin-Zhen Xie; Wen-Jie Yan; Geng-Xiang Wu; Jin Yang
Journal:  J Ovarian Res       Date:  2015-09-23       Impact factor: 4.234

Review 7.  New insights into the pathophysiology of ovarian hyperstimulation syndrome. What makes the difference between spontaneous and iatrogenic syndrome?

Authors:  A Delbaere; G Smits; O Olatunbosun; R Pierson; G Vassart; S Costagliola
Journal:  Hum Reprod       Date:  2004-01-29       Impact factor: 6.918

8.  A new way of setting rFSH deposit: a case of severe injection error in IVF/ICSI cycle ending with live birth.

Authors:  Richard Bernhard Mayer; Thomas Ebner; Omar Shebl; Gernot Tews
Journal:  J Turk Ger Gynecol Assoc       Date:  2012-09-01

9.  Correlation between steroid hormonal levels and cardiac function in women during controlled ovarian hyperstimulation.

Authors:  Yiran Li; Xiuhua Sun; Lili Zang; Quan Zhang; Jichun Li; Shuhua Zou
Journal:  Endocrine       Date:  2013-04-11       Impact factor: 3.633

10.  Ovarian Hyperstimulation Syndrome Is Associated with a High Secondary Sex Ratio in Fresh IVF Cycles with Cleavage-Stage Embryo Transfer: Results for a Cohort Study.

Authors:  Qiongqiong Jia; Lanlan Fang; Zhen Wang; Ze Wu; Yang Yan; Boqun Liu; Jung-Chien Cheng; Ying-Pu Sun
Journal:  Reprod Sci       Date:  2021-06-03       Impact factor: 3.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.